What's new

Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 4, Status: Authorised

Mar 26, 2025 - 17:13
 0
Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

FDA approves first-of-its-kind antibiotic from GSK

Next Article

Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab e...

Related Posts

Veterinary medicines European public assessment report (EPAR): Porcilis PCV, adjuvanted inactivated vaccine against porcine circovirus, Status: Authorised

Veterinary medicines European public assessment report ...

Mar 14, 2025  0

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0